# Senior Director, Therapeutic Area Analytics & Insights - Immunology (IMM) at Genentech

- Company: Genentech
- What the company does: Genentech discovers, develops, manufactures and commercializes treatments for patients with serious and life-threatening medical conditions. Backed by North Carolina Biotechnology Center.
- Company website: https://gene.com
- Type: Startups
- Level: Principal and up
- Location: South San Francisco
- Work setup: On-site
- Posted: 2026-09-15
- Apply by: 2026-10-30
- Apply: https://roche.wd3.myworkdayjobs.com/en-US/ROG-A2O-GENE/job/South-San-Francisco/Senior-Director--Therapeutic-Area-Analytics---Insights----Immunology--IMM-_202608-121411-1
- Page: https://www.1752.vc/careers/jobs/genentech-senior-director-therapeutic-area-analytics-and-insights-immunology-imm/

## About the role

The Senior Director, Therapeutic Area Analytics & Insights - Immunology (IMM) at Genentech is a visionary leader responsible for setting the strategic direction of analytics across Therapeutic Areas in Commercial, Medical, and Government Affairs (CMG). This role guides a multidisciplinary team of experts, leveraging core capabilities such as Market Research, Forecasting, Competitive Intelligence, Access, Data Analytics, Digital Measurement, Customer Insights, and Business Development.

## What they're looking for

- Preferred degree in Business, Economics, Engineering, Statistics, Life Sciences, Mathematics, Computer or Physical Sciences or related field
- MBA/graduate degree preferred
- Expertise in heterogeneous nature of autoimmune and inflammatory diseases, including rheumatoid arthritis, lupus, and/or inflammatory bowel disease (IBD)
- Understanding of the diagnostic challenges, treatment complexity, and evolving therapeutic landscape—including biologics, targeted therapies, and immune-modulating agents—in immunology
- Expertise in competitive and customer insights, with experience guiding strategies across commercial teams
- Expertise in business development insights, with experience guiding strategies across pipeline development, market access, and therapeutic areas